<DOC>
	<DOCNO>NCT02875158</DOCNO>
	<brief_summary>Transscleral cyclophotocoagulation ciliary body effective technique reduce intraocular pressure case glaucoma . Due concern complication , main indication second-line treatment refractory glaucoma medication / surgery low visual prognosis . The 2000 milliwatt ( mW ) 2 second setting use majority researcher clinician accord publish literature . Some propose use 1250 mW 4 second improve use medical procedure . The aim study determine different parameter affect efficacy treatment . This prospective double-blinded randomize control trial compare two group , experimental group use 1250 mW 4 second control group use 2000 mW 2 second .</brief_summary>
	<brief_title>Cyclophotocoagulation Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<criteria>Patients poorly control high pressure glaucoma Cyclophotocoagulation necessary prevent visual loss Cyclophotocoagulation necessary prevent reduce ocular discomfort Patient already undergone cyclophotocoagulation cryotherapy treatment eye glaucoma Patients receive concomitant treatment day intervention Patient able follow prescribe postoperative treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>